Latest Breaking News On - Roberto bellini - Page 4 : comparemela.com

BELLUS Health Inc.: GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health

Acquisition further strengthens specialty medicines and respiratory pipeline with camlipixant, a highly selective P2X3 antagonist and potential best-in-class treatment for refractory chronic cough

GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health

BELLUS Health Announces Positive Results from its Phase 1 Bioavailability Equivalence Study Evaluating Once-Daily Extended-Release Formulation of Camlipixant in Comparison to Twice-Daily Immediate Release Formulation

Once-daily Extended-Release formulation demonstrated equivalent bioavailability to twice-daily Immediate Release formulation Extended-Release formulation was well tolerated, with the safety profile. | April 5, 2023

3 Biotech Stocks to Buy Before the Down Market Is Over

Biotech stocks are high-risk, high-reward investments, although three names are buying opportunities in the current down market.

3 Growth Stocks You Can Buy Right Now with Less Than $100

Capital of less than $100 is enough to buy one of these three promising growth stocks that don't belong to the technology sector. Capital of less than $100 is enough to buy one of these three promising growth stocks that don't belong to the technology sector.